Expression and function of death receptors and their natural ligands in the intestine

Annals of the New York Academy of Sciences

Volumn 915, Issue , 2000, Pages 162-170

  Sträter, Jörn ^a   Möller, Peter ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER CELL CULTURE; CELL REGENERATION; COLON CARCINOMA; CONFERENCE PAPER; ENTERITIS; HUMAN; IMMUNOCOMPETENT CELL; MOLECULAR CLONING; NONHUMAN; PROTEIN DOMAIN;

EID: 0034519894     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05239.x     Document Type: Conference Paper

References (54)

1. Modulation of life and death by the TNF receptor superfamily
2. Death receptors: Signaling and modulation
3. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
4. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis
5. In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis
6. Fas and FasL in the homeostatic regulation of immune responses
7. The F as counterattack: Cancer as a site of immune privilege
8. The polypeptide encoded by the cDNA for human cell surface Fas can mediate apoptosis
9. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis/nerve growth factor receptor superfamily
10. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily
11. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium
12. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis
13. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
14. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
15. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
16. Fas involvement in cytotoxicity mediated by human NK cells
17. Activated B cells express functional Fas ligand
18. CD95 ligand (CD95L) in normal human lymphoid tissues: A subset of plasma cells are prominent producers of CD95L
19. Paneth cells express high levels of CD95 ligand transcripts. A unique property among gastrointestinal epithelia
20. A role for CD95 ligand in preventing graft rejection
21. Fas ligand-induced apoptosis as a mechanism of immune privilege
22. The role of FasL-induced apoptosis in immune privilege
23. The Fas counter-attack: Fas-mediated T cell killing by colon carcinoma cells expressing Fas ligand
24. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
25. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion?
26. Anti-Fas on nonhematopoetic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
27. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis
28. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
29. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
30. Fas/Fas ligand interaction in human colorectal hepatic metastases. A mechanism of hepatocyte destruction to facilitate local tumor invasion
31. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
32. Downregulation of Fas ligand by shedding
33. Identification and characterization of a new member of the TNF family that induces apoptosis
34. Induction of apoptosis by APO-2 ligand, a new member of the tumor necrosis factor cytokine family
35. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage
36. The receptor for the cytotoxic ligand TRAIL
37. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
38. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
39. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
40. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
41. A novel receptor for APO-2L/TRAIL contains a truncated death domain
42. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
43. Osteoprotegerin: A novel secreted protein involved in the regulation of bone densitiy
44. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
45. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
46. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
47. Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells
48. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
49. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
50. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vitro
51. Lethal effect of the anti-Fas antibody in mice
52. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
53. TRAIL/Apo-2-ligand-induced apoptosis in human T cells
54. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity